Artivion, Inc.

NYSE:AORT Stock Report

Market Cap: US$1.2b

Artivion Future Growth

Future criteria checks 4/6

Artivion is forecast to grow earnings and revenue by 123.9% and 9.7% per annum respectively while EPS is expected to grow by 125.7% per annum.

Key information

123.9%

Earnings growth rate

125.7%

EPS growth rate

Medical Equipment earnings growth17.0%
Revenue growth rate9.7%
Future return on equityn/a
Analyst coverage

Good

Last updated10 Dec 2024

Recent future growth updates

Recent updates

Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)

Dec 19
Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)

When Should You Buy Artivion, Inc. (NYSE:AORT)?

Nov 07
When Should You Buy Artivion, Inc. (NYSE:AORT)?

Returns At Artivion (NYSE:AORT) Are On The Way Up

Sep 28
Returns At Artivion (NYSE:AORT) Are On The Way Up

Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)

Sep 06
Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)

Is Artivion (NYSE:AORT) A Risky Investment?

Jun 28
Is Artivion (NYSE:AORT) A Risky Investment?

Data-Driven Growth Fuels More Upside For Overlooked Artivion

Jun 21

Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

May 08
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

Is Artivion (NYSE:AORT) Using Too Much Debt?

Jan 13
Is Artivion (NYSE:AORT) Using Too Much Debt?

Artivion Stock: A First Assessment

Dec 27

Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump

Nov 23
Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump

Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025

Oct 13

Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)

Jul 20

Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

May 10
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher

Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet

Mar 09
Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet

Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M

Feb 16

Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold

Dec 18

Artivion (NYSE:AORT) Is Making Moderate Use Of Debt

Sep 29
Artivion (NYSE:AORT) Is Making Moderate Use Of Debt

Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver

Sep 27

Earnings and Revenue Growth Forecasts

NYSE:AORT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202647720N/A424
12/31/20254307N/A456
12/31/20243921N/A226
9/30/2024385-1623N/A
6/30/2024377-81019N/A
3/31/2024368-10619N/A
12/31/2023354-31619N/A
9/30/2023340-24-68N/A
6/30/2023329-28-105N/A
3/31/2023320-29-20-11N/A
12/31/2022314-19-14-5N/A
9/30/2022314-41-14-4N/A
6/30/2022309-17-22-11N/A
3/31/2022305-15-150N/A
12/31/2021299-15-16-3N/A
9/30/20212872-112N/A
6/30/2021280-12-313N/A
3/31/2021258-13-57N/A
12/31/2020253-17-112N/A
9/30/2020255-14-58N/A
6/30/2020258-11-1013N/A
3/31/2020275-5-717N/A
12/31/20192762-716N/A
9/30/20192742425N/A
6/30/201927131521N/A
3/31/201926811621N/A
12/31/2018263-3410N/A
9/30/2018248-5-15N/A
6/30/2018227-5N/A0N/A
3/31/2018207-2N/A-3N/A
12/31/20171904N/A11N/A
9/30/20171829N/A10N/A
6/30/201718311N/A16N/A
3/31/201718210N/A22N/A
12/31/201618011N/A20N/A
9/30/201617510N/A16N/A
6/30/20161679N/A12N/A
3/31/20161557N/A12N/A
12/31/20151464N/A11N/A
9/30/20151433N/A15N/A
6/30/20151443N/A12N/A
3/31/20151436N/A11N/A
12/31/20141457N/A8N/A
9/30/201414214N/A9N/A
6/30/201414115N/A14N/A
3/31/201414015N/A16N/A
12/31/201314116N/A17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AORT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: AORT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AORT is expected to become profitable in the next 3 years.

Revenue vs Market: AORT's revenue (9.7% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: AORT's revenue (9.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AORT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Artivion, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raymond MyersBenchmark Company
Jason MillsCanaccord Genuity
Raymond MyersEmerging Growth Equities, Ltd.